A Roadmap to Better Breathing: Achieving Treatment Goals in Moderate-to-Severe Asthma
This enduring educational program is designed to assist healthcare providers who care for adult patients with moderate-to-severe asthma in reducing exacerbations and hospitalizations and improving patient treatment adherence and quality of life. This program will help learners to better align treatment regimens with evidence-based asthma management guidelines, summarize evidence-based best practices to optimize patient education, and employ current clinical evidence on the use of biologic agents in patients with moderate-to-severe asthma.
RELEASED DATE: October 29, 2024
EXPIRATION DATE: October 29, 2025
Approaches to Achieving Treatment Objectives for Patients with MODERATE TO SEVERE ASTHMA
Learn More & View Event »
Can Biologics Targeting Type 2 Inflammatory Mediators Play a Role in the Management of Patients with COPD?
Learn More & View Event »
Destination Breathe Easy: An In-Depth Look into The Patient’s Journey with Chronic Obstructive Pulmonary Disease
This program has been developed to educate practitioners who care for patients with chronic obstructive pulmonary disease (COPD) on the emerging role of pro-inflammatory cytokines in COPD progression and treatment, improve their understanding of the evolving clinician trial landscape, and impart strategies to improve patient education and communication. The program provides a unique opportunity to hear the patient’s perspective on their disease journey, and from the treating physician on the clinical strategy that was implemented to manage disease symptoms.
RELEASED DATE: October 30, 2024
EXPIRATION DATE: October 30, 2025
Individualizing Patient Care in COPD: Treating the Underlying Endophenotype and Use of Multidisciplinary Teams
This enduring activity is designed to provide healthcare professionals with a comprehensive understanding of the role of type 2 inflammation in the pathophysiology of Chronic Obstructive Pulmonary Disease (COPD) and its implications for treatment strategies. The latest developments in the treatment of COPD using approved and investigational biologics will be discussed featuring evidence-based and real-world experiences. Participants will gain valuable insights into improving the management of COPD using a multidisciplinary approach.
RELEASED DATE: May 17, 2025
EXPIRATION DATE: May 17, 2026
Management of Chronic Obstructive Pulmonary Disease Using Evidence-Based Approaches
Learn More & View Event »
Moderate-to-Severe Asthma: Targeting Underlying Inflammatory Processes to Improve Patient Outcomes
This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.
Navigate the Complexities of MODERATE-TO-SEVERE ASTHMA from DIAGNOSIS to TREATMENT Selection in Veteran Patients
Meeting Date: October 22, 2025
Time: 12:00 PM - 1:00 PM ET
Faculty Speaker: Katherine Richards, MD
Navigate the Complexities of MODERATE-TO-SEVERE ASTHMA from DIAGNOSIS to TREATMENT Selection in Veteran Patients
Meeting Date: December 2, 2025
Time: 1:00 PM - 2:00 PM ET
Faculty Speaker: Amir Sharafkhaneh, MD
Navigate the Complexities of MODERATE-TO-SEVERE ASTHMA from DIAGNOSIS to TREATMENT Selection in Veteran Patients
Meeting Date: December 4, 2025
Time: 3:00 PM - 4:00 PM ET
Faculty Speaker: Amir Sharafkhaneh, MD
